EVOGENE LTD.

EVGN XNAS

Market Cap

6.1M

Short interest (May 15)

1.3%

Net Short (Jun 03 ): -0.4%

Borrow Fee

13.34%

↑ 3.5%

Available Shares

300K

↓ 20.7%

Price Chart

Company Overview

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.

Company Info

Exchange: NASDAQ
CIK: 0001574565
Asset Type: CS

Market Data

Market Cap: $6,144,572
Employees: 52
Status: Active

Short Interest

Current Borrow Fee 13.34%
Range: 12.60% - 13.34%
Available Shares 300K
Range: 15K - 450K

Recent Changes

Fee Change: ↑ 7.8%
Available Change: ↓ 0.0%

Quick Actions

View Dilution Chart
Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam Unsubscribe anytime